World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
44614
World Ranking
15356
National Ranking
513

John D. Horowitz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John D. Horowitz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 643 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John D. Horowitz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Horowitz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John D. Horowitz is affiliated with the University of Adelaide in Australia and has contributed extensively to the field of medicine, with a particular focus on cardiology and cardiovascular medicine. Their research spans multiple subfields, including radiology, nuclear medicine and imaging, physiology, surgery, and neurology.

The scientist's work prominently features investigations into cardiac imaging and diagnostics, Takotsubo cardiomyopathy and related phenomena, nitric oxide and endothelin effects, as well as atrial fibrillation management and outcomes. Other main topics include cardiovascular function and risk factors, heart failure treatment and management, and cardiac arrhythmias and treatments.

Key recent papers authored or coauthored by Horowitz include:

  • Coexistence and outcome of coronary artery disease in Takotsubo syndrome (2020), European Heart Journal
  • Age-Related Variations in Takotsubo Syndrome (2020), Journal of the American College of Cardiology
  • Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome From Myocardial Infarction (2022), JAMA Cardiology
  • Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry (2021), Journal of the American Heart Association
  • Coronary "Microvascular Dysfunction": Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics (2023), International Journal of Molecular Sciences

Frequent coauthors collaborating with Horowitz include:

  • Thanh H. Nguyen
  • Yuliy Y. Chirkov
  • Sven Y Surikow
  • Gao Jing Ong
  • Victoria L. Cammann

Their research has been published repeatedly in specific venues such as:

  • Heart Lung and Circulation
  • European Heart Journal
  • International Journal of Molecular Sciences
  • Circulation Research
  • Reviews in Cardiovascular Medicine

The distribution of Horowitz's published work shows a significant emphasis on both clinical and molecular aspects of cardiovascular medicine, linking diagnostic techniques with the management and pathophysiology of heart conditions.

Best Publications

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

    Milton Packer;Philip A. Poole-Wilson;Paul W. Armstrong;John G. F. Cleland

  • International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology

    Jelena Rima Ghadri;Ilan Shor Wittstein;Abhiram Prasad;Scott Sharkey

  • Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study

    Simon Stewart;John E Marley;John D Horowitz

  • International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management

    Jelena Rima Ghadri;Ilan Shor Wittstein;Abhiram Prasad;Scott Sharkey

  • Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care

    Simon Stewart;Sue Pearson;John D. Horowitz

  • Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

    Renato D. Lopes;John H. Alexander;Sana M. Al-Khatib;Jack Ansell

  • PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial

    Paul W. Armstrong;N. Bett;D. Brieger;D. Chew

  • The Coronary Slow Flow Phenomenon – A New Coronary Microvascular Disorder

    John F. Beltrame;Sananand B. Limaye;John D. Horowitz

  • International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina

    E Topol;R Califf;F Van De Werf;R Diaz

  • Home-based intervention in congestive heart failure: long-term implications on readmission and survival.

    Simon Stewart;John D. Horowitz

  • Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.

    Barry F. Uretsky;Kristian Thygesen;Paul W. Armstrong;John G. Cleland

  • Metabolic Modulation With Perhexiline in Chronic Heart Failure A Randomized, Controlled Trial of Short-Term Use of a Novel Treatment

    Leong Lee;Ross Campbell;Michaela Scheuermann-Freestone;Rachel Taylor

  • Prolonged Beneficial Effects of a Home-Based Intervention on Unplanned Readmissions and Mortality Among Patients With Congestive Heart Failure

    Simon Stewart;Annette Joy Vandenbroek;Sue Pearson;John David Horowitz

  • Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.

    Leong Lee;John Horowitz;Michael Frenneaux

  • Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

    Lars Wallentin;Ziad Hijazi;Ulrika Andersson;John H. Alexander

  • Long-Term Prognosis of Patients With Takotsubo Syndrome

    Jelena R. Ghadri;Ken Kato;Victoria L. Cammann;Sebastiano Gili

  • Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy.

    Kuljit Singh;Kristin V Carson;Zafar A Usmani;Gagandeep Sawhney

  • Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.

    J D Horowitz;E M Antman;B H Lorell;W H Barry

  • N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

    Ziyad Hijazi;Lars Wallentin;Agneta Siegbahn;Ulrika Andersson

Frequent Co-Authors

Michael P. Frenneaux
Michael P. Frenneaux University of East Anglia
Simon Stewart
Simon Stewart Torrens University Australia
Elaine M. Hylek
Elaine M. Hylek Boston University
Lars Wallentin
Lars Wallentin Uppsala University
Renato D. Lopes
Renato D. Lopes Duke University
Thomas F. Lüscher
Thomas F. Lüscher University of Zurich
Christopher B. Granger
Christopher B. Granger Duke University
John H. Alexander
John H. Alexander Duke University
Frank Ruschitzka
Frank Ruschitzka University of Zurich
Michael G. Hanna
Michael G. Hanna University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those inspired by studying Medicine in the USA but looking for flexible or alternative pathways, online degrees in nursing and related fields offer accessible and affordable options. Many students are drawn to nurse practitioner programs for their blend of advanced clinical skills and career versatility. These programs can often be completed fully online, allowing you to balance your studies with work or personal commitments.

Cost is a major consideration, so researching what is the cheapest online college for nursing? can help you find quality programs within your budget. Additionally, for those seeking higher qualifications, there are options like the cheapest DNP programs, which prepare nurses for leadership roles or advanced practice positions.

Registered nurses interested in advancing their qualifications should explore the RN to BSN online cost. These degrees can open doors to more opportunities and higher salaries. No matter your starting point, online healthcare degrees can help you step confidently into the medical field and achieve your professional goals.

Best Scientists Citing John D. Horowitz

Trending Scientists

Recently Published Articles